USA Drug Delivery Devices Market by Route of Administrations (Topical, Ocular, Oral, Injectable, and Others), Applications (Infectious Diseases, Diabetes, Cardiovascular, Cancer, and Others), End-users (Ambulatory Surgical Centers, Hospitals, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The USA drug delivery devices market size is expected to register a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the reduction in the side effects of the drugs if available at the location for use. Drug delivery devices decrease the side effects of drugs and also reduce the cost of the product with the help of various ingredients available at the pharmaceuticals.
Drug delivery device is a specialized tool that helps to deliver drugs through different route of administration. These devices are mainly used for treatment of wide variety of diseases. There are various ways by which medications can be taken including inhalation, absorption, intravenous injection, through skin, and swallowing. Drug delivery devices control the location and rate of drug released in the body.
These devices can be implantable or conventional. Drug delivery devices have different features including specific therapeutic effect, high degree of safety, target specificity, dose optimization, and efficiency. For this, drug delivery devices are used to deliver drugs in the specific device type. The drug delivery devices have changed suddenly in past few decades and even more changes are anticipated in the coming future. Increasing geriatric population in USA and growing adoption of biologics is estimated to fuel the market.
Market Trends, Drivers, Restraints, and Opportunities
- Rising spread of various chronic diseases is expected to boost the market growth in the coming years.
- Rapid growth of the healthcare industry is key factors spurring the market expansion.
- Stringent government regulations and policies related to delivery devices are projected to hamper the market growth during the forecast period.
- Inefficient drug delivery devices for soluble drugs present as major factors that can restrict the market expansion.
- R&D investment and technological advancement in drug delivery devices are estimated to create lucrative opportunities for the market players.
Scope of the Report
The report on the USA drug delivery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
USA Drug Delivery Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Route of Administrations (Topical, Ocular, Oral, Injectable, and Others), Applications (Infectious Diseases, Diabetes, Cardiovascular, Cancer, and Others), End-users (Ambulatory Surgical Centers, Hospitals, and Others) |
|
Country |
USA |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
F.Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc.; Bayer AG; Novartis AG; and Johnson & Johnson |
Market Segment Insights:
Injectable segment is projected to constitute a major market share
In terms of route of administration, the USA Drug Delivery Devices market is segregated into topical, ocular, oral, injectable, and others. The injectable segment is expected to account for a key share of the market during the forecast period owing to innovation and adoption of various new technologies including pre-filled syringes & different types of injectors coming in the market. However, the oral segment is anticipated to expand at a rapid pace during the forecast period due to easy availability, usage, stability, and highly preferred. There are various types of oral system available in the market that includes suspensions, tablets, capsules, syrups, and solutions.
Cancer segment is projected to hold a key market share
On the basis of applications, the market is segmented into infectious diseases, diabetes, cardiovascular, cancer, and others. The cancer segment is expected to represent a key share of the market in the coming years due to rising number of cancer cases as well as patients and people are getting aware about the treatments available for cancer. On the other hand, the infectious diseases segment is anticipated to expand at a rapid pace during the forecast period owing to growing incidences of hepatitis, pneumonia, HIV-AIDS, tuberculosis, and others.
Hospitals segment is projected to account for a large market share
Based on end-users, the USA Drug Delivery Devices market is divided into ambulatory surgical centers, hospitals, and others. The hospitals segment is expected to constitute a key share of the market during the forecast period owing to high usage of drugs for different treatments and growing various diseases and infections. However, the ambulatory surgical centers segment is anticipated to expand at a rapid pace during the forecast period due to rising focus in development and adoption of the drug delivery devices.
Segments
Segments Covered in the Report
The USA Drug Delivery Devices market has been segmented on the basis of
Route of Administration
- Topical
- Ocular
- Oral
- Injectable
- Others
Applications
- Infectious Diseases
- Diabetes
- Cardiovascular
- Cancer
- Others
End-users
- Ambulatory Surgical Centers
- Hospitals
- Others
Country
- USA
Key Players
- F.Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc.
- Bayer AG
- Novartis AG
- Johnson & Johnson
Competitive Landscape
Key players competing in the USA Drug Delivery Devices market include F.Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc.; Bayer AG; Novartis AG; and Johnson & Johnson. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Delivery Devices Market - Supply Chain
4.5. Global Drug Delivery Devices Market Forecast
4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
5.3.1. Infectious Diseases
5.3.2. Diabetes
5.3.3. Cardiovascular
5.3.4. Cancer
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
6.3.1. Ambulatory Surgical Centers
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
8.4.1. Infectious Diseases
8.4.2. Diabetes
8.4.3. Cardiovascular
8.4.4. Cancer
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
8.7.1. Ambulatory Surgical Centers
8.7.2. Hospitals
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
9.4.1. Infectious Diseases
9.4.2. Diabetes
9.4.3. Cardiovascular
9.4.4. Cancer
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
9.7.1. Ambulatory Surgical Centers
9.7.2. Hospitals
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
10.4.1. Infectious Diseases
10.4.2. Diabetes
10.4.3. Cardiovascular
10.4.4. Cancer
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
10.7.1. Ambulatory Surgical Centers
10.7.2. Hospitals
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
11.4.1. Infectious Diseases
11.4.2. Diabetes
11.4.3. Cardiovascular
11.4.4. Cancer
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
11.7.1. Ambulatory Surgical Centers
11.7.2. Hospitals
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
12.4.1. Infectious Diseases
12.4.2. Diabetes
12.4.3. Cardiovascular
12.4.4. Cancer
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
12.7.1. Ambulatory Surgical Centers
12.7.2. Hospitals
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Drug Delivery Devices Market: Market Share Analysis
13.2. Drug Delivery Devices Distributors and Customers
13.3. Drug Delivery Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. F.Hoffmann-La Roche Ltd.
13.4.2. GlaxoSmithKline Plc.
13.4.3. Bayer AG
13.4.4. Novartis AG
13.4.5. Johnson & Johnson
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Delivery Devices Market - Supply Chain
4.5. Global Drug Delivery Devices Market Forecast
4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
5.3.1. Infectious Diseases
5.3.2. Diabetes
5.3.3. Cardiovascular
5.3.4. Cancer
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
6.3.1. Ambulatory Surgical Centers
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
8.4.1. Infectious Diseases
8.4.2. Diabetes
8.4.3. Cardiovascular
8.4.4. Cancer
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
8.7.1. Ambulatory Surgical Centers
8.7.2. Hospitals
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
9.4.1. Infectious Diseases
9.4.2. Diabetes
9.4.3. Cardiovascular
9.4.4. Cancer
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
9.7.1. Ambulatory Surgical Centers
9.7.2. Hospitals
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
10.4.1. Infectious Diseases
10.4.2. Diabetes
10.4.3. Cardiovascular
10.4.4. Cancer
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
10.7.1. Ambulatory Surgical Centers
10.7.2. Hospitals
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
11.4.1. Infectious Diseases
11.4.2. Diabetes
11.4.3. Cardiovascular
11.4.4. Cancer
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
11.7.1. Ambulatory Surgical Centers
11.7.2. Hospitals
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
12.4.1. Infectious Diseases
12.4.2. Diabetes
12.4.3. Cardiovascular
12.4.4. Cancer
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
12.7.1. Ambulatory Surgical Centers
12.7.2. Hospitals
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Drug Delivery Devices Market: Market Share Analysis
13.2. Drug Delivery Devices Distributors and Customers
13.3. Drug Delivery Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. F.Hoffmann-La Roche Ltd.
13.4.2. GlaxoSmithKline Plc.
13.4.3. Bayer AG
13.4.4. Novartis AG
13.4.5. Johnson & Johnson
Segments Covered in the Report
The USA Drug Delivery Devices market has been segmented on the basis of
Route of Administration
- Topical
- Ocular
- Oral
- Injectable
- Others
Applications
- Infectious Diseases
- Diabetes
- Cardiovascular
- Cancer
- Others
End-users
- Ambulatory Surgical Centers
- Hospitals
- Others
Country
- USA
Key Players
- F.Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc.
- Bayer AG
- Novartis AG
- Johnson & Johnson
Key players competing in the USA Drug Delivery Devices market include F.Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc.; Bayer AG; Novartis AG; and Johnson & Johnson. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Our Clients
Related Reports
Some other reports from this category!
